Clinical trial
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin…
NCT03690778 · Jeil Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT03690778 |
|---|---|
| Title | The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers. |
| Official title | A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 (1000/10mg) in Healthy Male Volunteers. |
| Lead sponsor | Jeil Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes, Hyperlipidemias |
| Intervention type | Drug |
| Interventions | "Metformin" and "Rosuvastatin" seperately, JLP-1310 |
| Enrollment | 42 |
| Start date | Oct 4, 2018 |
| Primary completion | Feb 1, 2019 |
| Completion | Feb 1, 2019 |
| First posted | Oct 1, 2018 |
| Last update posted | Mar 29, 2019 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: